The great vaccine debate involves questions of clinical practice, policy, and ethics. Is there a limit to the number of acceptable vaccines for children? What risks are acceptable to demand of members of the public to protect others? Who should assess the level of risk in vaccinations?
The summer 2015 edition of Virginia Tech Magazine explores the university community's various roles in the fight against cancer; remembers the life and career of the late Paul Torgersen, Virginia Tech's president from 1994 through 2000; overviews campus construction projects to improve traffic flow; and examines a catapult-like device designed by the Virginia Tech chapter of the Society of American Military Engineers.
Harald Sontheimer, who joined Virginia Tech earlier this month to direct a university-wide neuroscience initiative, will hold the I. D. Wilson Chair in the College of Science. That appointment was recently approved by the Virginia Tech Board of Visitors.
In a study using functional magnetic resonance imaging, Virginia Tech Carilion Research Institute scientists found that our inherent risk-taking preferences affect how we view and act on information from other people.
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it isn’t hypothetical – the researchers were recently awarded a grant from the Commonwealth Research Commercialization Fund, part of the Center for Innovative Technology, to engineer a viral therapy.
During the past few years, Virginia Tech's Wu Feng http://www.cs.vt.edu/user/feng has built upon a National Science Foundation (NSF) / Microsoft grant from the "Computing in the Cloud" program, and synergistically complemented it with subsequent collaborative grants, including a $6 million award from the Air Force on "big computing" for mini-drones and a $1 million award from NSF and the National Institutes of Health on "big data" for the life sciences.